Palladia (Toceranib Phosphate) for Dogs, 50 mg (Brown), Mast Cell Tumor Treatment for Dogs

★★★★★ 4.6 98 reviews

US$837.01
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by caped.co
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$837.01
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Aug 22
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by caped.co
Free 30-day returns Details

Product details

Management number 240214902 Release Date 2026/07/16 List Price US$837.01 Model Number 240214902
Category

Palladia (toceranib phosphate) tablets is an FDA-approved treatment for canine mast cell tumors. It is indicated for Patnaik grades 2 or 3, concurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs. Palladia combines antiangiogenic and antiproliferative properties to kill these tumors by cutting off their blood supply and inhibiting the production of cancerous cells. It’s available by prescription only. Follow your veterinarian’s instructions as prescribed.

  • Palladia 50 mg Tablet - 1 Tablet
  • PALLADIA tablets are indicated for the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs.
  • Toceranib is used to treat cancer in dogs. The FDA (U.S. Food & Drug Administration) has approved this drug for use in dogs for treatment of some stages of canine mast cell tumors. You and your veterinarian can discuss why this drug is the most appropriate choice.

Animal type Dog
Drug brand name Palladia
Medicine strength 50mg
Dosage Always provide Client Information Sheet with prescription. Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight, orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized, if needed, to manage adverse reactions. Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks, thereafter.
Prescription medicine type Prescription Medicine
Animal health concern Cancer
Pharmacy product status Active
Animal lifestage All Lifestages
Medicine form Oral
Enteral medication & supplement form Tablets
Pharmacy product category Branded RX
Container type Bottle
Count per pack 1
Fda approved for animals Y
Is intended for human consumption N
Shape Tablet
Items included 1 Tablet
Product net content parent 60 Each
Product net content uom Each
Size 50 mg
Dea class None/NC (Not Controlled)

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.6 out of 5
★★★★★
98 ratings | 40 reviews
How item rating is calculated
View all reviews
5 stars
84% (82)
4 stars
3% (3)
3 stars
2% (2)
2 stars
1% (1)
1 star
10% (10)
Sort by

There are currently no written reviews for this product.